161 related articles for article (PubMed ID: 17675942)
81. Primary tumors and mediastinal lymph nodes after neoadjuvant concurrent chemoradiotherapy of lung cancer: serial CT findings with pathologic correlation.
Lee KS; Shim YM; Han J; Kim J; Ahn YC; Park K; Jung KJ
J Comput Assist Tomogr; 2000; 24(1):35-40. PubMed ID: 10667655
[TBL] [Abstract][Full Text] [Related]
82. Automated TTF-1 Immunohistochemistry Assay for the Differentiation of Lung Adenocarcinoma Versus Lung Squamous Cell Carcinoma.
Cintrón RV; Martínez AJ; Jusino JA; Conte-Miller M; Mendoza A
Methods Mol Biol; 2021; 2279():1-12. PubMed ID: 33683681
[TBL] [Abstract][Full Text] [Related]
83. Single primary lung cancer consisting of three cancer cell types (small cell carcinoma, adenocarcinoma, and squamous cell carcinoma) in which each had metastasized to different lymph nodes.
Shikata H; Ueda Y; Tsuchishima S; Nonaka T; Watanabe Y; Matsubara J
Jpn J Thorac Cardiovasc Surg; 2002 May; 50(5):216-9. PubMed ID: 12048916
[TBL] [Abstract][Full Text] [Related]
84. The morphological and molecular diagnosis of lung cancer.
Petersen I
Dtsch Arztebl Int; 2011 Aug; 108(31-32):525-31. PubMed ID: 21886665
[TBL] [Abstract][Full Text] [Related]
85. Difficulties in diagnostics of lung tumours in biopsies: an interpathologist concordance study evaluating the international diagnostic guidelines.
Ericson Lindquist K; Ciornei C; Westbom-Fremer S; Gudinaviciene I; Ehinger A; Mylona N; Urdar R; Lianou M; Svensson F; Seidal T; Haglund F; Dobra K; Béndek M; Bardóczi E; Szablewska A; Witkowski M; Ramnefjell M; De Las Casas LE; Gulyas M; Hegedus A; Micke P; Brunnström H
J Clin Pathol; 2022 May; 75(5):302-309. PubMed ID: 33547095
[TBL] [Abstract][Full Text] [Related]
86. Indications and pitfalls of immunohistochemistry in head and neck cancer.
Caly Dde N; Viana A; Rapoport A; Dedivitis RA; Curioni OA; Cernea CR; Brandão LG
Braz J Otorhinolaryngol; 2013; 79(1):75-81. PubMed ID: 23503911
[TBL] [Abstract][Full Text] [Related]
87. Large cell neuroendocrine carcinoma of the lung.
Barbareschi M; Mariscotti C; Barberis M; Frigo B; Mosca L
Tumori; 1989 Dec; 75(6):583-8. PubMed ID: 2559526
[TBL] [Abstract][Full Text] [Related]
88. The advancement of predictive diagnosis and molecular mechanism in multiple primary lung cancer.
Yuan L; Liu LX; Che GW
Chin J Cancer; 2010 May; 29(5):575-8. PubMed ID: 20426912
[TBL] [Abstract][Full Text] [Related]
89. Application of immunohistochemistry to the diagnosis of primary and metastatic carcinoma to the lung.
Jagirdar J
Arch Pathol Lab Med; 2008 Mar; 132(3):384-96. PubMed ID: 18318581
[TBL] [Abstract][Full Text] [Related]
90. Exfoliative cytologic evaluation of primary cultured lung carcinomas.
Resau JH; Albright CD; Cottrell JR; Colombo-Burke KL; Aisner SC; Miura I; Testa JR
Cytotechnology; 1991 Jun; 6(2):143-52. PubMed ID: 16724425
[TBL] [Abstract][Full Text] [Related]
91. An Update on the Role of Immunohistochemistry in the Evaluation of Gastrointestinal Tract Disorders.
Robertson S; Patil DT
Adv Anat Pathol; 2020 May; 27(3):193-205. PubMed ID: 30234501
[TBL] [Abstract][Full Text] [Related]
92. Large cell lung carcinoma with unusual imaging feature, immunophenotype and genetic finding.
Stojsic J; Stevic R; Kontic M; Stojsic Z; Drndarevic N; Bunjevacki V; Jekic B
Pathol Oncol Res; 2011 Mar; 17(1):175-9. PubMed ID: 20405348
[TBL] [Abstract][Full Text] [Related]
93. Immunohistochemistry for assessment of pulmonary and pleural neoplasms: a review and update.
Tan D; Zander DS
Int J Clin Exp Pathol; 2008 Jan; 1(1):19-31. PubMed ID: 18784820
[TBL] [Abstract][Full Text] [Related]
94. Immunohistochemistry in Dermatopathology and its Relevance in Clinical Practice.
Chatterjee D; Bhattacharjee R
Indian Dermatol Online J; 2018; 9(4):234-244. PubMed ID: 30050812
[TBL] [Abstract][Full Text] [Related]
95. Intraoperative rapid immunohistochemistry with noncontact antibody mixing for undiagnosed pulmonary tumors.
Imai K; Nanjo H; Shigeeda W; Sugai T; Ito T; Maniwa Y; Takashima S; Saito H; Yanagawa N; Tanaka Y; Doi T; Hiroshima Y; Nomura K; Tanino M; Tanaka S; Minamiya Y;
Cancer Sci; 2023 Feb; 114(2):702-711. PubMed ID: 36282212
[TBL] [Abstract][Full Text] [Related]
96. Molecular and Morphological Profiling of Lung Cancer: A Foundation for "Next-Generation" Pathologists and Oncologists.
Kashima J; Kitadai R; Okuma Y
Cancers (Basel); 2019 Apr; 11(5):. PubMed ID: 31035693
[TBL] [Abstract][Full Text] [Related]
97. [Histology, cytology and molecular diagnostics of lung cancer].
Mairinger T
Pathologe; 2019 Nov; 40(6):649-661. PubMed ID: 31602505
[TBL] [Abstract][Full Text] [Related]
98. Utility of Immunohistochemistry in the Diagnosis of Pleuropulmonary and Mediastinal Cancers: A Review and Update.
Deng H
Arch Pathol Lab Med; 2024 Mar; 148(3):267-283. PubMed ID: 37406295
[TBL] [Abstract][Full Text] [Related]
99. Immunohistochemistry in the Diagnosis and Classification of Breast Tumors.
Sun H; Ding Q; Sahin AA
Arch Pathol Lab Med; 2023 Oct; 147(10):1119-1132. PubMed ID: 37490413
[TBL] [Abstract][Full Text] [Related]
100.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
